{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:06:12Z","timestamp":1793016372408,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jaip.2026.01.001","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:42:50Z","timestamp":1768264970000},"page":"899-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Validation of the Novel Pediatric Eosinophilic Esophagitis Sign\/Symptom Questionnaire-Caregiver Version in EoE KIDS"],"prefix":"10.1016","volume":"14","author":[{"given":"Mirna","family":"Chehade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilish","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Yaworsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger E.","family":"Lamoureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leighann","family":"Litcher-Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Burbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarette T.","family":"Tilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhesh","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S.","family":"Dellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.01.001_bib1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cgh.2024.09.031","article-title":"Prevalence and costs of eosinophilic esophagitis in the United States","volume":"23","author":"Thel","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2026.01.001_bib2","article-title":"Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessment. Guidance for industry, Food and Drug Administration staff, and other stakeholders","year":"2022","journal-title":"Silver Spring, MD: US Food and Drug Administration"},{"key":"10.1016\/j.jaip.2026.01.001_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaci.2018.05.014","article-title":"Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites","volume":"142","author":"Aceves","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.001_bib4","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jaip.2022.02.049","article-title":"Novel questionnaires for assessing signs and symptoms of eosinophilic esophagitis in children","volume":"10","author":"Kamat","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.001_bib5","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa2312282","article-title":"Dupilumab for eosinophilic esophagitis in patients 1 to 11 years of age","volume":"390","author":"Chehade","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.001_bib6","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1007\/s10620-009-1005-z","article-title":"Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia","volume":"55","author":"Dellon","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaip.2026.01.001_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaip.2026.01.001_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1037\/1082-989X.1.1.30","article-title":"Forming inferences about some intraclass correlation coefficients","volume":"1","author":"McGraw","year":"1996","journal-title":"Psychol Methods"},{"key":"10.1016\/j.jaip.2026.01.001_bib9","series-title":"Psychometric theory","author":"Nunnally","year":"1994"},{"key":"10.1016\/j.jaip.2026.01.001_bib10","series-title":"How to measure survey reliability and validity","author":"Litwin","year":"1995"},{"key":"10.1016\/j.jaip.2026.01.001_bib11","series-title":"Applied statistics for the behavioral sciences","author":"Hinkle","year":"2002"},{"key":"10.1016\/j.jaip.2026.01.001_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/apt.12413","article-title":"Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis","volume":"38","author":"Dellon","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2026.01.001_bib13","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/j.gastro.2014.08.028","article-title":"Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis","volume":"147","author":"Schoepfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2026.01.001_bib14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2021.14920","article-title":"Eosinophilic esophagitis: a review","volume":"326","author":"Muir","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2026.01.001_bib15","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.jaip.2026.01.001_bib16","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jaci.2024.07.011","article-title":"Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis","volume":"154","author":"Martin","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.001_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s41687-023-00646-z","article-title":"Qualitative assessment of the suitability of the Dysphagia Symptom Questionnaire to monitor dysphagia in children aged 7-10 years with eosinophilic esophagitis","volume":"7","author":"Pokrzywinski","year":"2023","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.jaip.2026.01.001_bib18","volume":"166","author":"Lucendo","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2026.01.001_bib19","article-title":"Eosinophilic esophagitis: developing drugs for treatment guidance for industry","year":"2020","journal-title":"Silver Spring, MD: US Food and Drug Administration;"},{"key":"10.1016\/j.jaip.2026.01.001_bib20","article-title":"Patient-focused drug development: methods to identify what is important to patients. Guidance for industry, Food and Drug Administration staff, and other stakeholders","year":"2022","journal-title":"Silver Spring, MD: US Food and Drug Administration;"},{"key":"10.1016\/j.jaip.2026.01.001_bib21","article-title":"Patient-focused drug development: incorporating clinical outcome assessments into endpoints for regulatory decision-making. Silver Spring, MD: US","year":"2023","journal-title":"Food and Drug Administration;"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:55:11Z","timestamp":1777625711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213219826000048"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.001","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the Novel Pediatric Eosinophilic Esophagitis Sign\/Symptom Questionnaire-Caregiver Version in EoE KIDS","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}